Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Randi

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Haematologica|January 1, 1989
The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombastheniaF Fabris, A Casonato, M L Randi, et al.
Leukemia|July 31, 2015
Mutational profile of childhood myeloproliferative neoplasmsA Karow, R Nienhold, P Lundberg, et al.
British Journal of Haematology|March 22, 2001
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpuraF Fabris, T Tassan, R Ramon, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1983
Platelet-specific proteins in patients with transient ischemic attacks. (Effects of anti-platelet drugs)F Fabris, M L Randi, M E Crociani, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Soluble plasma thrombomodulin levels in patients with chronic myeloproliferative disorderM L Randi, C Meneghin, P Zerbinati, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacksF Fabris, M L Randi, A Casonato, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Leukemia|June 7, 2013
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyA Tefferi, E Rumi, G Finazzi, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Haematologica|January 1, 1989
The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombastheniaF Fabris, A Casonato, M L Randi, et al.
Leukemia|July 31, 2015
Mutational profile of childhood myeloproliferative neoplasmsA Karow, R Nienhold, P Lundberg, et al.
British Journal of Haematology|March 22, 2001
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpuraF Fabris, T Tassan, R Ramon, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1983
Platelet-specific proteins in patients with transient ischemic attacks. (Effects of anti-platelet drugs)F Fabris, M L Randi, M E Crociani, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Soluble plasma thrombomodulin levels in patients with chronic myeloproliferative disorderM L Randi, C Meneghin, P Zerbinati, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacksF Fabris, M L Randi, A Casonato, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Leukemia|June 7, 2013
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyA Tefferi, E Rumi, G Finazzi, et al.
Pageof 9